BOSTON, Oct 25 (Reuters) - An injected version of Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Alzheimer's drug Leqembi works as well as the current intravenous version at ...

Dr. Eric K. Singhi discusses the benefit of subcutaneous immunotherapy following the FDA approval of subcutaneous Opdivo for patients with solid tumors. On Dec. 27, 2024, the Food and Drug ...

Add Yahoo as a preferred source to see more of our stories on Google. Bioengineers in South Korea have succeeded in developing an intravenous needle (IV) that can bend and flex as it enters the human ...

Roche’s Lunsumio may be the first CD20xCD3 T-cell engager approved by the FDA, but intravenous administration puts the drug at a disadvantage to AbbVie and Genmab’s subcutaneously injected Epkinly.

Intravenous (IV) injection is a method commonly used in patient’s treatment worldwide as it induces rapid effects and allows treatment through continuous administration of medication by directly ...

Patients who depend on antibody drugs often spend long hours in infusion centers. These medicines are vital for treating many cancers, autoimmune disorders and infectious diseases, but current ...

The FDA is requiring updated labeling for tranexamic acid injection to emphasize the risk of serious harm, including death, if administered incorrectly via spinal injection. Tranexamic acid injection ...

When Bea Amma visited a med spa in 2021, she was hoping for treatments that would boost her energy and help burn off some body fat. She never imagined she would end up with a drug-resistant infection ...

The Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study from drugmaker Eisai suggests, ...

The FDA confirmed the nationwide shortage of sodium chloride 0.9% injection, or IV saline, has officially ended. The IV saline shortage, which has affected hospitals and clinics across the country, is ...